http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002006935-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
filingDate | 2001-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b34fd081aa12080d67b5e1218a38f745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a2890685dd9187c3eb703288a414477 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e609a1bb246d5754b73fdf48c6f0e79 |
publicationDate | 2002-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2002006935-A1 |
titleOfInvention | 1-aryl-1,8-naphthylidin-4-one derivative as type IV phosphodiesterase inhibitor |
abstract | A 1-aryl-1,8-naphthylidin-4-one derivative having the formula (I): n n n wherein R 1 indicates a substituted or unsubstituted aryl group or a substituted or unsubstituted heteroaryl group, n R 2 , R 3 , and R 4 independently indicate a hydrogen atom, a substituted or unsubstituted lower alkyl group, or a halogen atom, n X indicates a group NR 5 R 6 or a group OR 7 , wherein R 5 and R 6 independently indicate a hydrogen a atom, a substituted or unsubstituted lower alkyl group, a substituted or unsubstituted cycloalkyl group, a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group, and R 7 indicates a hydrogen atom, a substituted or unsubstituted lower alkyl group, or a substituted or unsubstituted cycloalkyl group or a salt or solvate thereof and a type IV phosphodiesterase inhibitor containing the same as an effective component. |
priorityDate | 1997-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 726.